Medeon Biodesign Past Earnings Performance

Past criteria checks 0/6

Medeon Biodesign's earnings have been declining at an average annual rate of -29.5%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been declining at an average rate of 9.7% per year.

Key information

-29.5%

Earnings growth rate

-29.3%

EPS growth rate

Medical Equipment Industry Growth11.5%
Revenue growth rate-9.7%
Return on equity-49.5%
Net Margin-295.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Medeon Biodesign's (GTSM:6499) Stock Price Has Reduced 71% In The Past Five Years

Feb 09
Medeon Biodesign's (GTSM:6499) Stock Price Has Reduced 71% In The Past Five Years

Revenue & Expenses Breakdown

How Medeon Biodesign makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:6499 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24271-801198745
30 Jun 24212-811186715
31 Mar 24200-1,231178698
31 Dec 23196-1,205186667
30 Sep 23178-1,185199631
30 Jun 23173-1,115185612
31 Mar 23151-675179567
31 Dec 22298-434153522
30 Sep 22271-356125500
30 Jun 22240-410115460
31 Mar 22249-357109441
31 Dec 2169-540108416
30 Sep 21142-488105372
30 Jun 21141-426102336
31 Mar 21117-38997306
31 Dec 20123-37198290
30 Sep 20162-399114294
30 Jun 20279-351132300
31 Mar 20377-306140307
31 Dec 19454-262143301
30 Sep 19412-221130272
30 Jun 19350-200112240
31 Mar 19300-169106201
31 Dec 18674257107197
30 Sep 18639222108216
30 Jun 18604215109214
31 Mar 18596181109229
31 Dec 17165-248103216
30 Sep 17148-24097206
30 Jun 17120-24089199
31 Mar 1766-22578178
31 Dec 1629-21971163
30 Sep 160-20463154
30 Jun 160-18458150
31 Mar 160-17353149
31 Dec 150-14847135
30 Sep 150-11638110
30 Jun 150-1053296
31 Mar 150-842875
31 Dec 140-732465
30 Sep 140-572451
30 Jun 140-412537

Quality Earnings: 6499 is currently unprofitable.

Growing Profit Margin: 6499 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 6499 is unprofitable, and losses have increased over the past 5 years at a rate of 29.5% per year.

Accelerating Growth: Unable to compare 6499's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 6499 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (5%).


Return on Equity

High ROE: 6499 has a negative Return on Equity (-49.45%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/11 10:29
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medeon Biodesign, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hsiu Chi LinMasterlink Securities Corp.